(Q34108327)

31 July 2017

1 reference

title

Selective serotonin reuptake inhibitors for children and adolescents (English)

1 reference

31 July 2017

0 references

1 reference

Kastelic EA

1

1 reference

31 July 2017

Labellarte MJ

series ordinal

2

1 reference

31 July 2017

Riddle MA

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Current Psychiatry Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

117-123

1 reference

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0055-X

Medication development and testing in children and adolescents. Current problems, future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0055-X

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0055-X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0055-X

A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.

21 January 2018

1 reference

12 December 2020

Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study

1 reference

12 December 2020

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

1 reference

12 December 2020

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

12 December 2020

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

1 reference

12 December 2020

The Leyton Obsessional Inventory-Child Version

1 reference

12 December 2020

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

12 December 2020

Paroxetine pharmacokinetics in depressed children and adolescents.

1 reference

12 December 2020

Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy

1 reference

12 December 2020

Assessment of severity and change in obsessive compulsive disorder

1 reference

12 December 2020

Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.

1 reference

12 December 2020

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

12 December 2020

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

1 reference

12 December 2020

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

1 reference

12 December 2020

Cytochromes: a primer for child and adolescent psychiatrists

1 reference

12 December 2020

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial

1 reference

12 December 2020

Childhood and adolescent depression: a review of the past 10 years. Part II.

1 reference

12 December 2020

The treatment of anxiety disorders in children and adolescents

1 reference

12 December 2020

10.1007/S11920-000-0055-X

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1029990364

0 references

1 reference